Simultaneous diastereo- and enantioseparation of farnesoid X receptor (FXR) agonists with a quinine carbamate-based chiral stationary phase

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 2-3, 2013, Pages 847-862

  Sardella, Roccaldo ^a   Marinozzi, Maura ^a   Ianni, Federica ^a   Lisanti, Antonella ^a   Natalini, Benedetto ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Diastereoseparation; Enantioseparation; Farnesoid X receptor agonists; Ion exchange liquid chromatography; Normal phase conditions; Quinine carbamate based chiral stationary phase

Indexed keywords

LIQUID CHROMATOGRAPHY;

CHIRAL STATIONARY PHASE; DIASTEREOSEPARATION; ENANTIOSEPARATIONS; FARNESOID X RECEPTORS; ION EXCHANGE LIQUID CHROMATOGRAPHY; NORMAL PHASE;

ION EXCHANGE;

HUMAN ECHOVIRUS 1;

EID: 84873710571     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6348-1     Document Type: Article

References (43)

1. W Wang J Chen K Hollister LC Sowers BM Forman 1999 Endogenous bile acids are ligands for the nuclear receptor FXR/BAR Mol Cell 3 543 553 10.1016/S1097-2765(00)80348-2 1:CAS:528:DyaK1MXjslCqurg%3D
2. DJ Parks SG Blanchard RK Bledsoe G Chandra TG Consler SA Kliewer JB Stimmel TM Willson AM Zavacki DD Moore JM Lehmann 1999 Bile acids: natural ligands for an orphan nuclear receptor Science 284 1365 1368 10.1126/science.284.5418.1365 1:CAS:528:DyaK1MXjs1WhtLw%3D
3. M Makashima AY Okamoto JJ Repa H Tu RM Learned A Luk MV Hull KD Lustig DJ Mangelsdorf B Shan 1999 Identification of a nuclear receptor for bile acids Science 284 1362 1365 10.1126/science.284.5418.1362
4. CJ Sinal M Tohkin M Miyata JM Ward G Lambert FJ Gonzales 2000 Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis Cell 102 731 744 10.1016/S0092-8674(00)00062-3 1:CAS:528: DC%2BD3cXmvFShtr8%3D
5. TT Lu M Makishima JJ Repa K Schoonjans TA Kerr J Auwerx DJ Mangelsdorf 2000 Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors Mol Cell 6 507 515 10.1016/S1097-2765(00)00050-2 1:CAS:528: DC%2BD3cXntVyhs70%3D
6. R Gadaleda SWC van Mil B Oldenburg PD Siersema LWJ Klomp KJ van Erpecum 2010 Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease Biochim Biophys Acta 1801 683 692 10.1016/j.bbalip. 2010.04.006
7. YD Wang WD Chen W Huang 2008 FXR, a target for different diseases Histol Histopathol 23 621 627 1:CAS:528:DC%2BD1cXlslWkt7c%3D
8. R Pellicciari S Fiorucci E Camaioni C Clerici G Costantino PR Maloney A Morelli DJ Parks TM Willson 2002 6a-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity J Med Chem 45 3569 3572 10.1021/jm025529g 1:CAS:528:DC%2BD38XlsVSgs7s%3D
9. PR Maloney DJ Parks CD Haffner AM Fivush G Chandra KD Plunket KL Creech LB Moore JG Wilson MC Lewis SA Jones TM Willson 2000 Identification of a chemical tool for the orphan nuclear receptor FXR J Med Chem 43 2971 2974 10.1021/jm0002127 1:CAS:528:DC%2BD3cXltVSiur0%3D
10. A Akwabi-Ameyaw JY Bass RD Caldwell JA Caravella L Chen KL Creech DN Deaton SA Jones I Kaldor Y Liu KP Madauss HB Marr RB McFayden AB Miller F Navas III DJ Parks PK Spearing D Todd SP Williams GB Wisely 2008 Conformationally constrained farnesoid X receptor (FXR) agonists naphthoic acid-based analogs of GW 4064 Bioorg Med Chem Lett 18 4339 4343 10.1016/j.bmcl.2008.06.073 1:CAS:528:DC%2BD1cXptVeqtbk%3D
11. A Akwabi-Ameyaw JY Bass RD Caldwell JA Caravella L Chen KL Creech DN Deaton KP Madauss HB Marr RB McFayden AB Miller F Navas III DJ Parks PK Spearing D Todd SP Williams GB Wisely 2009 FXR agonist activity of conformationally constrained analogs of GW 4064 Bioorg Med Chem Lett 19 4733 4739 10.1016/j.bmcl.2009.06.062 1:CAS:528:DC%2BD1MXptVCrs7o%3D
12. JY Bass RD Caldwell JA Caravella L Chen KL Creech DN Deaton KP Madauss HB Marr RB McFayden AB Miller DJ Parks D Todd SP Williams GB Wisely 2009 Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW 4064 Bioorg Med Chem Lett 19 2969 2973 10.1016/j.bmcl.2009.04.047 1:CAS:528:DC%2BD1MXmtVeku70%3D
13. JY Bass JA Caravella L Chen KL Creech DN Deaton KP Madauss HB Marr RB McFayden AB Miller WY Mills F Navas III DJ Parks TL Smalley Jr PK Spearing D Todd SP Williams GB Wisely 2011 Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene Bioorg Med Chem Lett 21 1206 1213 10.1016/j.bmcl.2010.12.089 1:CAS:528:DC%2BC3MXhs1amt74%3D
14. A Akwabi-Ameyaw JA Caravella L Chen KL Creech DN Deaton KP Madauss HB Marr AB Miller F Navas III DJ Parks PK Spearing D Todd SP Williams GB Wisely 2011 Conformationally constrained farnesoid X receptor (FXR) agonists: alternative replacements of the stilbene Bioorg Med Chem Lett 21 6154 6160 10.1016/j.bmcl.2011.08.034 1:CAS:528:DC%2BC3MXhtF2qsr7E
15. B Flatt R Martin TL Wang P Mahaney B Murphy XH Gu P Foster J Li P Pircher M Petrowski I Schulman S Westin J Wrobel G Yan E Bischoff C Daige R Mohan 2009 Discovery of XL335 (WAY-362450), a highly potent, selective, and orally active agonist of the farnesoid X receptor (FXR) J Med Chem 52 904 907 10.1021/jm8014124 1:CAS:528:DC%2BD1MXhtVCgsL4%3D
16. S Feng M Yang Z Zhang Z Wang D Hong H Richter GM Benson K Bleicher U Grether RE Martin JM Plancher B Kuhn MG Rudolph L Chen 2009 Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist Bioorg Med Chem Lett 19 2595 2598 10.1016/j.bmcl.2009.03.008 1:CAS:528:DC%2BD1MXkslyiu7Y%3D
17. HGF Richter GM Benson KH Bleicher D Blum E Chaput N Clemann S Feng C Gardes U Grether P Hartman B Kuhn RE Martin JM Plancher MG Rudolph F Schuler S Taylor 2011 Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties Bioorg Med Chem Lett 21 1134 1140 10.1016/j.bmcl.2010.12.123 1:CAS:528: DC%2BC3MXhs1amsbs%3D
18. HGF Richter GM Benson D Blum E Chaput S Feng C Gardes U Grether P Hartman B Kuhn RE Martin JM Plancher MG Rudolph F Schuler S Taylor KH Bleicher 2011 Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes Bioorg Med Chem Lett 21 191 194 10.1016/j.bmcl.2010.11.039 1:CAS:528:DC%2BC3cXhs1SqsLfI
19. M Downes MA Verdecia AJ Roecker R Hughes JB Hogenesch HR Kast-Woelbern ME Bowman JL Ferrer AM Anisfeld PA Edwards JM Rosenfeld JGA Alvarez JP Noel KC Nicolaou RMA Evans 2003 Chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR Mol Cell 11 1079 1092 10.1016/S1097-2765(03) 00104-7 1:CAS:528:DC%2BD3sXjslGhtro%3D
20. U Abel T Schlueter A Schulz E Hambruch C Steeneck M Hornberger T Hoffmann S Perovic-Ottstadt O Kinzel M Burnet U Deuschle C Kremoser 2010 Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists Bioorg Med Chem Lett 20 4911 4917 10.1016/j.bmcl.2010.06.084 1:CAS:528:DC%2BC3cXptlans7k%3D
21. D Schuster P Markt U Grienke J Mihaly-Bison M Binder SM Noha JM Rollinger H Stuppner VN Bochkov G Wolbera 2011 Pharmacophore-based discovery of FXR agonists. Part I: model development and experimental validation Bioorg Med Chem 19 7168 7180 10.1016/j.bmc.2011.09.056 1:CAS:528:DC%2BC3MXhsVehsr%2FL
22. M Marinozzi A Carotti E Sansone A Macchiarulo E Rosatelli R Sardella B Natalini G Rizzo L Adorini D Passeri F De Franco M Pruzanski R Pellicciari 2012 Pyrazole[3,4-e][1,4]thiazepin-7-one derivatives as a novel class of farnesoid X receptor (FXR) agonists Bioorg Med Chem 20 3429 3445 10.1016/j.bmc.2012.04.021 1:CAS:528:DC%2BC38Xms12rt7s%3D
23. Maier NM, Lindner W (2006) In: Francotte E, Lindner W (eds) Chirality in drug research. WILEY, Weinheim
24. Lämmerhofer M, Lindner W (2008) In: Grushka E, Grinberg N (eds) Advances in chromatography, vol 46. CRC Press, Boca Raton
25. Natalini B, Sardella R (2012) In: Tranter G (ed) Comprehensive chirality. Elsevier, Amsterdam
26. R Sardella M Lämmerhofer B Natalini W Lindner 2008 In-line coupling of reversed-phase and quinine carbamate-based anion-exchange type chiral stationary phase to cope with limited chemoselectivity on the latter: a case study illustrated for simultaneous T3 and T4 enantiomer separation J Sep Sci 31 1702 1711 10.1002/jssc.200800058 1:CAS:528:DC%2BD1cXnvVWnur4%3D
27. M Lämmerhofer O Gyllenhaal W Lindner 2004 HPLC enantiomer separation of a chiral 1,4-dihydropyridine monocarboxylic acid J Pharm Biomed Anal 35 259 266 10.1016/S0731-7085(03)00644-7
28. ACD/Labs Software version 7.0
29. H Gika M Lämmerhofer I Papadoyannis W Lindner 2004 Direct separation and quantitative analysis of thyroxine and triiodothyronine enantiomers in pharmaceuticals by high-performance liquid chromatography J Chromatogr B 800 193 201 10.1016/j.jchromb.2003.07.005 1:CAS:528:DC%2BD3sXhtVSjtb3K
30. A Péter 2002 Direct high-performance liquid chromatographic enantioseparation of apolar β-amino acids on a quinine-derived chiral anionexchanger stationary phase J Chromatogr A 955 141 150 10.1016/S0021- 9673(02)00192-9
31. M Lämmerhofer P Imming W Lindner 2004 Direct high-performance liquid chromatographic enantiomer separation of anti-inflammatory planar chiral [2.2]paracyclophane-4-acetic acid Chromatographia 60 S13 S17 10.1365/s10337-004-0187-y
32. R Sardella M Lämmerhofer B Natalini W Lindner 2006 Enantioselective HPLC of potentially CNS-active acidic amino acids with a cinchona carbamate based chiral stationary phase Chirality 20 571 576 10.1002/chir.20529
33. W Bicker M Lämmerhofer W Lindner 2004 Direct high-performance liquid chromatographic method for enantioselective and diastereoselective determination of selected pyrethroic acids J Chromatogr A 1035 37 46 10.1016/j.chroma.2004.02.036 1:CAS:528:DC%2BD2cXivVGjurs%3D
34. M Yang S Fazio D Munch P Drumm 2005 Impact of methanol and acetonitrile on separations based on π-π interactions with a reversed-phase phenyl column J Chromatogr A 1097 124 129 10.1016/j.chroma.2005.08.028 1:CAS:528:DC%2BD2MXht1egtbfJ
35. X Xiong WRG Baeyens HY Aboul-Enein JR Delanghe T Tu J Ouyang 2007 Impact of amines as co-modifiers on the enantioseparation of various amino acid derivatives on a tert-butyl carbamoylated quinine-based chiral stationary phase Talanta 71 573 581 10.1016/j.talanta.2006.04.038 1:CAS:528: DC%2BD2sXotFSksw%3D%3D
36. K Gyimesi-Forras K Akasaka M Lämmerhofer NM Maier T Fujita M Watanabe N Harada W Lindner 2005 Enantiomer separation of a powerful chiral auxiliary, 2-methoxy-2-(1-naphthyl)propionic acid by liquid chromatography using chiral anion exchanger-type stationary phases in polar-organic mode; investigation of molecular recognition aspects Chirality 17 S134 S142 10.1002/chir.20123 1:CAS:528:DC%2BD2MXmtF2lurs%3D
37. D Lubda W Lindner 2004 Monolithic silica columns with chemically bonded tert-butylcarbamoylquinine chiral anion-exchanger selector as a stationary phase for enantiomer separations J Chromatogr A 1036 135 143 10.1016/j.chroma.2004. 03.016 1:CAS:528:DC%2BD2cXjtFantbg%3D
38. CV Hoffmann R Reischl NM Maier M Lämmerhofer W Lindner 2009 Investigations of mobile phase contributions to enantioselective anion- and zwitterion-exchange modes on quinine-based zwitterionic chiral stationary phases J Chromatogr A 1216 1157 1166 10.1016/j.chroma.2008.12.044 1:CAS:528: DC%2BD1MXhtFens7c%3D
39. K Gyimesi-Forrás NM Maier J Kökösi A Gergely W Lindner 2009 Enantiomer separation of imidazo-quinazoline-dione derivatives on quinine carbamate-based chiral stationary phase in normal phase mode Chirality 21 199 207 10.1002/chir.20640
40. E Soczewiński 1977 Solvent composition effects in liquid-solid systems J Chromatogr 130 23 28 10.1016/S0021-9673(00)89777-0
41. TD Booth IW Wainer 1996 Investigation of the enantioselective separations of α-alkylarylcarboxylic acids on an amylose tris(3,5- dimethylphenylcarbamate) chiral stationary phase using quantitative structure-enantioselective retention relationships Identification of a conformationally driven chiral recognition mechanism J Chromatogr A 737 157 169 10.1016/0021-9673(96)00011-8 1:CAS:528:DyaK28XktlOgs7Y%3D
42. KH Krawinkler NM Maier E Sajovic W Lindner 2004 Novel urea-linked cinchona-calixarene hybrid-type receptors for efficient chromatographic enantiomer separation of carbamate-protected cyclic amino acids J Chromatogr A 1053 119 131 1:CAS:528:DC%2BD2cXos1yqur8%3D
43. 18 packings J Chromatogr Sci 35 525 535